Human Mesenchymal Stem Cells – Whartons Jelly (HMSC-WJ)

Human Mesenchymal Stem Cells derived from Wharton’s Jelly (HMSC-WJ) represent a unique and versatile subset of mesenchymal stromal cells (MSCs). These cells are isolated from the gelatinous substance within the umbilical cord, offering a more primitive source of MSCs compared to those derived from adult tissues like bone marrow or adipose tissue. This primitive nature contributes to their higher proliferation rates, lower immunogenicity, and enhanced differentiation potential. Notably, HMSC-WJ can differentiate into a wide variety of cell types, including adipocytes, osteoblasts, and chondrocytes, under specific in vitro conditions, making them highly valuable for research into regenerative medicine, tissue engineering, and cellular therapies.

One of the key differentiators of HMSC-WJ from other MSCs is their non-invasive and ethically favorable source, as the umbilical cord is typically discarded after birth. This eliminates the ethical concerns and donor morbidity associated with harvesting MSCs from bone marrow or adipose tissue. Furthermore, HMSC-WJ demonstrate superior immunomodulatory properties and a lower risk of transformation compared to MSCs from other sources, making them an attractive option for both in vitro studies and potential therapeutic applications.

The cultured HMSC-WJ are cryopreserved at early passages using a specific cryomedium to ensure high viability and functionality upon thawing. Each cryovial contains a minimum of 1 x 106 cells, with viability levels consistently ranging between 92% to 95% as determined by the Trypan Blue dye exclusion test. These cells are collected from healthy donors, all of whom have provided informed consent for the use of their cell material. Rigorous quality control measures are applied to each batch of HMSC-WJ, ensuring that they meet strict criteria for identification, purity, potency, and viability, thereby guaranteeing their appropriateness for research purposes.